Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”

por Bienvenu, B., Cozon, G., Hoarau, C., Pasquet, M., Cherin, P., Clerson, P., Hachulla, E., Crave, J. C., Delain, J. C., Jaussaud, R.
Publicado 2016

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial

por Viallard, J. F., Agape, P., Barlogis, V., Cozon, G., Faure, C., Fouyssac, F., Gaud, C., Gourin, M. P., Hamidou, M., Hoarau, C., Husseini, F., Ojeda-Uribe, M., Pavic, M., Pellier, I., Perlat, A., Schleinitz, N., Slama, B.
Publicado 2016